![]() |
![]() | |||||
|
Lamictal RX Facts
What is a seizure?A seizure occurs when the brain’s electrical activity is periodically disturbed which results in some major or minor degree of temporary brain dysfunction. There are two basic types of seizures: 1) Epileptic --these have no apparent cause or trigger and occur repeatedly. This is referred to as a “seizure disorder” or “epilepsy.” 2) Non-epileptic -- seizures triggered by a disorder or another condition that is an irritant to the brain. What is Lamictal RX?Lamictal RX is the brand name of an
anti-seizure medication called Lamotrigine.
Lamictal RX is produced
by GlaxoSmithKline.
It’s used in combination with other medications to
treat partial seizures in people 13 years and older.
It’s a preferred seizure medication because it’s only
taken in one daily dose.
The XR in the name stands for extended relief.
The medicine is released into the bloodstream in a
steady level throughout the day.
It’s important to take Lamictal RX at the same time
each day, perhaps associating it with getting up in the
morning or at a regular meal.
That way the dose will maintain a consistent level
and it will be easier to remember to take.
If a dose is missed, a double dose should not be
taken. Lamictal
RX shouldn’t be crushed or mixed with anything, but taken
whole. It should be stored at room temperature, not in the
refrigerator, and obviously kept away from children. How Does Lamictal
RX Work?
The proposed mechanism of action for
Lamotrigine involves an effect it has on sodium channels,
while this in not established in humans.
In vitro pharmacological studies it inhibits voltage
in sensitive sodium channels, stabilizing neuronal
membranes.
Consequently this modulates presynoptic transmitter release
of excitatory amino acids such as glutamate and aspartate. What is the History of Lamictal
RX?
In December 1994 Lamictal was approved for use in treatment of partial seizures. In August 1998 it was used as an adjunctive treatment of Lennox--Gastault syndrome in pediatric and adult patients. It was available in a chewable, dispersible tablet. In December of 1998 it was used as a monotherapy for treatment of partial seizures in adult patients when converting from a single enzyme-inducing anti-epileptic drug (EIAED). In January 2003 Lamictal began to be used as an adjunctive therapy for partial seizures in pediatric patients as young as two. In June of 2003 it was initiated as a maintenance medication for Bipolar I disorder, the first since lithium. In January 2004 Lamictal was used as a monotherapy for treatment of partial seizures in adult patients when converting from the anti-epileptic drug valproate, including valproic acid (Depakene); sodium valprotae (Epilim) and divalproex (Depakote).
| |||||
|
| ||||||
|
|
|
| ||||